(SAMPLE ONLINE MODULE) C. difficile: Where have we been, and where are we now?
Therapeutic measures for prevention of recurrent C. difficile infections.
Pharmacists from the University of Pittsburgh School of Pharmacy and/or employed by UPMC and deployed throughout the hospital campus in unit-based roles and centrally in the department of pharmacy's main pharmacy.
- Describe the epidemiology and risk factors of C. difficile infection
- Define the current standard of treatment and prevention for initial and reoccurring C. difficile infections
- Identify and compare recent advancements in the pharmacologic management of C. difficile infections
Vivian Tsai, PharmD Candidate 2020
Nikitha Yagnala, PharmD Candidate 2021
- 1.00 AMA PRA Category 1 Credit™The University of Pittsburgh School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
- 1.00 Attendance